Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

about

A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes.CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy

P2860

Q34063596-AE426DFC-CDA5-40BA-BEC4-E3970742003E Q34621578-E7416556-B50A-4B19-B308-742DAD1CEA39

P2860

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

Item

http://www.wikidata.org/entity/Q36487452

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

@ast

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

@en

type

Item

label

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

@ast

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

@en

prefLabel

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

@ast

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

@en

P1476

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

@en

P2093

Andrea M Henle

http://www.w3.org/2001/XMLSchema#string

Courtney L Erskine

http://www.w3.org/2001/XMLSchema#string

Keith L Knutson

http://www.w3.org/2001/XMLSchema#string

Linda M Benson

http://www.w3.org/2001/XMLSchema#string

Raphael Clynes

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

T Cell Receptor Cross-reactivity Directed by Antigen-Dependent Tuning of Peptide-MHC Molecular Flexibility

Trastuzumab--mechanism of action and use in clinical practice

SYFPEITHI: database for MHC ligands and peptide motifs

Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior.

Antigenicity and immunogenicity of peptide analogues of a low affinity peptide of the human telomerase reverse transcriptase tumor antigen.

Role of HER2 gene overexpression in breast carcinoma.

Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines.

Cross-reactivity in T-cell antigen recognition.

P304

479-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1201264

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233770767

http://www.w3.org/2001/XMLSchema#string

P698

23180824

http://www.w3.org/2001/XMLSchema#string

P932

3529812

http://www.w3.org/2001/XMLSchema#string

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

about

P2860

P2860

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932